Mirati Announces Clinical Collaboration to Evaluate MRTX849 in Combination with SHP2 Inhibitor TNO155 Read more
Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics Read more
Under the spotlight: Amgen’s VP for the Center of Observational Research Will Discuss the Role of RWE in a Comprehensive Product Evidence Generation Plan Read more
Ligand and SQ Innovation Enter into Exclusive Worldwide Captisol License and Supply Agreements for High-Concentration Furosemide Formulation Read more
Priority Review Granted to BeiGene’s Supplemental New Drug Application in China for Tislelizumab in Urothelial Carcinoma Read more
Grifols Announces FDA Approval of Xembify, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies Read more